Tag | Content |
---|
EnhancerAtlas ID | HS074-01162 |
Organism | Homo sapiens |
Tissue/cell | GM19239 |
Coordinate | chr1:192574030-192575060 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ZNF263 | MA0528.1 | chr1:192574867-192574888 | GATGGAAGGAGGAAGGGAGGG | + | 6.06 | ZNF263 | MA0528.1 | chr1:192574879-192574900 | AAGGGAGGGAGGGGGAGAAAG | + | 6.24 | ZNF263 | MA0528.1 | chr1:192574889-192574910 | GGGGGAGAAAGAGAATGAGAG | + | 6.36 | ZNF263 | MA0528.1 | chr1:192574924-192574945 | GAGGGAGGGAGGAGGAGGGAG | + | 6.74 | ZNF263 | MA0528.1 | chr1:192574938-192574959 | GAGGGAGGGGGAAAGAGAGAA | + | 6.75 | ZNF263 | MA0528.1 | chr1:192574916-192574937 | AGAGGAGAGAGGGAGGGAGGA | + | 7.27 | ZNF263 | MA0528.1 | chr1:192574883-192574904 | GAGGGAGGGGGAGAAAGAGAA | + | 7.46 | ZNF263 | MA0528.1 | chr1:192574934-192574955 | GGAGGAGGGAGGGGGAAAGAG | + | 7.92 | ZNF263 | MA0528.1 | chr1:192574928-192574949 | GAGGGAGGAGGAGGGAGGGGG | + | 8.12 | ZNF263 | MA0528.1 | chr1:192574874-192574895 | GGAGGAAGGGAGGGAGGGGGA | + | 8.37 | ZNF263 | MA0528.1 | chr1:192574931-192574952 | GGAGGAGGAGGGAGGGGGAAA | + | 8.94 | ZNF263 | MA0528.1 | chr1:192574871-192574892 | GAAGGAGGAAGGGAGGGAGGG | + | 9.25 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_43694 | chr1:192571742-192577024 | MM1S | SE_58423 | chr1:192573180-192611301 | Ly1 | SE_59607 | chr1:192571834-192620763 | Ly4 | SE_60433 | chr1:192573416-192610588 | DHL6 | SE_61104 | chr1:192573010-192610405 | HBL1 | SE_61454 | chr1:192540780-192610346 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 192574180 | 192574494 | chr1 | 192574140 | 192574567 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I192605 | chr1 | 192574180 | 192574494 |
|
Enhancer Sequence | AAATGCTTTA CAAGTAATGT TTTACATAAA ATTTAATTAT TATGAATAAA TAGAACCTTT 60 AAAAACTAAA TCTTTCAAGA TTATATTCAT TCAAATGGAA ATAGCTAAAT TTGTGCATGA 120 ATATCAGATG ACTTCTTCCT GCCTTGGTTA CTAATGAATG GCCAAGCTTG TTTCTATAAA 180 TAAATGGGCA CTGGCATATT TTTTAAAAAA TACATGTGGC TCAAGATTAG ACTTCTTCCG 240 CTTTGTGGTA TCACATGTCT GACCACAGCA ACTATTTTAA ATCATGGTCT ATGCTTTTAA 300 TGACATCTAA CTCCACACAA AGAGTCATCA TTTTTATCTA GACGTGTGTG ACGTGCTTGA 360 TTGCAATGTG TTTTTTTTTT GTGTGTGTGT GTTGTTGTTT TTCTCTTTAT CATTTTAACA 420 TGCATTTCTA TAATACTTTG GTAATCTTGA AAACACTCAG GTCACCTTAC AACATCAAGA 480 CAGGCATAGA CCACTGTTTC CTTAAGTCTA TAAAGTTTTG TTATAAAAAT TGGGTAGCCA 540 GCTGTTCTTG GCCTAACATT AATCTAATAA AAGTGTTTCC AAAGAAAGTT TATGGAATGA 600 AAATTCATTG CTATTATTTT CAACTTTAAT TGAATTTTTA AATAAAAACA CTAAAAACTA 660 AACAATAGTA TTGAATACTA CTATTGGAAT TCATAGCTGG GCATGGCAGT GCATGCCTAT 720 AATCCCAGCT ACTCAGGATG CTGAGGCAGA AGGACTACTT GAGGCCAGAA GTTTGAGACT 780 AGCCTGAGCA ATATAGAAAA TCCTGTCTTA CATGAAATAC AGAAAGAAAG AGAGACAGAT 840 GGAAGGAGGA AGGGAGGGAG GGGGAGAAAG AGAATGAGAG AAAGAGAGAG GAGAGAGGGA 900 GGGAGGAGGA GGGAGGGGGA AAGAGAGAAA GAAAGAAAGA CAGAAAGAAA GAAAGACAGA 960 CAGACAGACA GACAGACAGA CAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA 1020 AAGAAAGAGG 1030
|